AMNOG
Evidence Graph
Ask
Cases
Sources
Explore / Assessment
Assessment
Selumetinib
Cancer
Modules
IQWiG assessments · G-BA decisions
Connections
2
Connected evidence
2 relations
owns document
1
Outgoing
Nutzenbewertung IQWiG
Document
has assessment · incoming
1
Incoming
Selumetinib (Neues Anwendungsgebiet: Neurofibromatose Typ 1 (≥ 18 Jahre))
Procedure